Literature DB >> 17965124

A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis.

A H M van der Helm-van Mil1, S M van der Kooij, C F Allaart, R E M Toes, T W J Huizinga.   

Abstract

BACKGROUND: Obesity is a state of chronic low-grade inflammation that predisposes people to several diseases and that is increasingly prevalent. Rheumatoid arthritis (RA) is marked by the presence of proinflammatory cytokines and, in general, the presence of high levels of inflammatory markers is associated with a severe disease course and joint damage.
OBJECTIVES: To evaluate prospectively (a) whether obesity is a risk factor for the development of RA and (b) whether the body mass index (BMI) is associated with the amount of joint destruction in early RA after 3 years' follow-up.
METHODS: In a cohort of 570 patients with undifferentiated arthritis, the relation between the BMI and the development of RA during 1 year of follow-up was assessed. In a cohort of 488 patients with early RA the correlation between the BMI and degree of radiological joint destruction (Sharp-van der Heijde score) after 3 years of follow-up was determined. The findings were replicated in an independent cohort of 247 patients with early RA.
RESULTS: Obesity did not influence the likelihood of developing RA. In both RA cohorts, the BMI was inversely correlated with the Sharp-van der Heijde score after 3 years' follow-up (r = -0.15, p = 0.025 for the Leiden EAC and r = -0.27, p<0.001 for the replication cohort). Linear regression analyses in both cohorts showed that the BMI was independently and inversely associated with the level of joint destruction in anti-CCP-positive patients with RA, but not in anti-CCP-negative patients.
CONCLUSIONS: A high BMI is associated with a less severe disease outcome in anti-CCP-positive patients with RA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965124     DOI: 10.1136/ard.2007.078832

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  63 in total

Review 1.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

2.  Predictors of longterm changes in body mass index in rheumatoid arthritis.

Authors:  Joshua F Baker; Grant W Cannon; Said Ibrahim; Candace Haroldsen; Liron Caplan; Ted R Mikuls
Journal:  J Rheumatol       Date:  2015-04-01       Impact factor: 4.666

Review 3.  Can Rheumatologists Predict Eventual Need for Orthopaedic Intervention in Patients with Rheumatoid Arthritis? Results of a Systematic Review and Analysis of Two UK Inception Cohorts.

Authors:  Elena Nikiphorou; Lewis Carpenter; Sam Norton; Stephen Morris; Alex MacGregor; Josh Dixey; Peter Williams; Patrick Kiely; David Andrew Walsh; Adam Young
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

4.  Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Bryant R England; Ted R Mikuls; Harlan Sayles; Grant W Cannon; Brian C Sauer; Michael D George; Liron Caplan; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-12       Impact factor: 4.794

5.  Lack association of body mass index with disease activity composites of rheumatoid arthritis in Korean population: cross-sectional observation.

Authors:  Jung-Yoon Choe; Jisuk Bae; Hwajeong Lee; Sung-Hoon Park; Seong-Kyu Kim
Journal:  Clin Rheumatol       Date:  2013-11-08       Impact factor: 2.980

6.  Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.

Authors:  Young Hee Rho; Joseph Solus; Tuulikki Sokka; Annette Oeser; Cecilia P Chung; Tebeb Gebretsadik; Ayumi Shintani; Theodore Pincus; C Michael Stein
Journal:  Arthritis Rheum       Date:  2009-07

7.  Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib.

Authors:  Diana S Novikova; Helen V Udachkina; Eugenia I Markelova; Irina G Kirillova; Anna S Misiyuk; Natalia V Demidova; Tatiana V Popkova
Journal:  Rheumatol Int       Date:  2019-05-03       Impact factor: 2.631

8.  Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

Authors:  Florenzo Iannone; Delphine S Courvoisier; Jacques Eric Gottenberg; Maria Victoria Hernandez; Elisabeth Lie; Helena Canhão; Karel Pavelka; Merete Lund Hetland; Carl Turesson; Xavier Mariette; Denis Choquette; Axel Finckh
Journal:  Clin Rheumatol       Date:  2016-12-14       Impact factor: 2.980

Review 9.  Rheumatoid arthritis and metabolic syndrome.

Authors:  György Kerekes; Michael T Nurmohamed; Miguel A González-Gay; Ildikó Seres; György Paragh; Zsófia Kardos; Zsuzsa Baráth; László Tamási; Pál Soltész; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2014-08-05       Impact factor: 20.543

10.  Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats.

Authors:  Andrea Stofkova; Blanka Zelezna; Marianna Romzova; Olga Ulicna; Alexander Kiss; Martina Skurlova; Jana Jurcovicova
Journal:  Mediators Inflamm       Date:  2010-09-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.